We are live on ! Find out more
IMNM icon

Immunome
IMNM

35 hedge funds and large institutions have $15.4M invested in Immunome in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 6 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 6

65% more capital invested

Capital invested by funds: $9.34M → $15.4M (+$6.08M)

19% more call options, than puts

Call options by funds: $312K | Put options by funds: $263K

17% more funds holding

Funds holding: 30 → 35 (+5)

0.73% more ownership

Funds ownership: 15.22% → 15.95% (+0.73%)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
35
Holders Change
+5
Holders Change %
+16.67%
% of All Funds
0.55%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
5
Increased
11
Reduced
6
Closed
–
Calls
$312K
Puts
$263K
Net Calls
+$49K
Net Calls Change
+$163K

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$2.29M
2
Renaissance Technologies
Renaissance Technologies
New York
+$85.3K
3
Cerity Partners
Cerity Partners
New York
+$75.3K
4
HBCM
Heron Bay Capital Management
Michigan
+$71.9K
5
Simplex Trading
Simplex Trading
Illinois
+$56.8K

Top Sellers

Rank Fund Capital Flow
1
PCM
Prentice Capital Management
Connecticut
-$1.75M
2
Millennium Management
Millennium Management
New York
-$457K
3
Citadel Advisors
Citadel Advisors
Florida
-$10.1K
4
HighTower Advisors
HighTower Advisors
Illinois
-$5.47K
5
NFSG
Newbridge Financial Services Group
Florida
-$820
Name Holding Trade Value Shares
Change 		Change in
Stake
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$3.31M +$2.29M +418,127 New
Vanguard Group
2
Vanguard Group
Pennsylvania
$2.96M – – –
AGM
3
Alpine Global Management
New York
$2.89M – – –
PCM
4
Prentice Capital Management
Connecticut
$887K -$1.75M -319,773 -74%
Bank of Montreal
5
Bank of Montreal
Ontario, Canada
$800K +$42.3K +7,741 +8%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$642K – – –
Cerity Partners
7
Cerity Partners
New York
$531K +$75.3K +13,779 +26%
Millennium Management
8
Millennium Management
New York
$522K -$457K -83,644 -56%
Renaissance Technologies
9
Renaissance Technologies
New York
$352K +$85.3K +15,600 +54%
BlackRock
10
BlackRock
New York
$343K +$9.7K +1,773 +4%
State Street
11
State Street
Massachusetts
$234K – – –
Royal Bank of Canada
12
Royal Bank of Canada
Ontario, Canada
$228K +$4.69K +858 +3%
MFG
13
Magnus Financial Group
New York
$204K – – –
BIM
14
Baldwin Investment Management
Pennsylvania
$201K – – –
SIAP
15
Sterling Investment Advisors (Pennsylvania)
Pennsylvania
$171K – – –
Susquehanna International Group
16
Susquehanna International Group
Pennsylvania
$138K +$26.9K +4,913 +39%
Northern Trust
17
Northern Trust
Illinois
$132K -$481 -88 -0.5%
Simplex Trading
18
Simplex Trading
Illinois
$132K +$56.8K +10,381 +162%
HighTower Advisors
19
HighTower Advisors
Illinois
$126K -$5.47K -1,000 -6%
Dimensional Fund Advisors
20
Dimensional Fund Advisors
Texas
$122K – – –
Morgan Stanley
21
Morgan Stanley
New York
$107K +$7.31K +1,336 +11%
HBCM
22
Heron Bay Capital Management
Michigan
$104K +$71.9K +13,139 New
WA
23
Wealth Architects
California
$87.9K – – –
Group One Trading
24
Group One Trading
Illinois
$60.9K – – –
FIA
25
FNY Investment Advisers
New York
$27K +$19.1K +3,500 New
1
2

IMNM Hedge Fund Activity: Q2 2023 in Review

35 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Immunome (IMNM) for Q2 2023, worth a combined $15.4M — up 65% from $9.34M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new IMNM positions and 0 closed out — a net gain of 5 holders — while 11 added to existing stakes and 6 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $2.29M. The largest seller was Prentice Capital Management, cutting an estimated $1.75M.

  • 35 institutional investors held Immunome (IMNM) as of Q2 2023, up from 30 in Q1 2023.
  • Funds reported $15.4M of Immunome stock for Q2 2023, up 65% quarter-over-quarter.
  • 5 funds opened new Immunome positions in Q2 2023 and 0 closed out, a net change of +5 holders.
  • The largest Immunome buyer in Q2 2023 was Point72 Asset Management, an estimated $2.29M added.
  • The largest Immunome seller in Q2 2023 was Prentice Capital Management, an estimated $1.75M sold.

Based on aggregated 13F filings for Q2 2023.